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Summary
Purpose: The aim of this study was to evaluate the effect of two different concentrations (4 and 8 mg) of dexametha-
sone to decrease the swelling and trismus after the surgical extraction of mandibular impacted third molars. 
Methods: This  randomized clinical trial comprised thirty (30) adult patients of both genders with no local or systemic 
problems, with bilateral impacted lower third molars in similar position, where surgical extraction had been indica-
ted. They were given 4 mg and 8 mg of dexamethasone 1 hour before the surgical procedure at the first or second 
surgery. The choice of which side to operate first and the amount of concentration of medication to use was made 
randomly and double-blindly.  Postoperative pain was evaluated using a visual analog scale (VAS) and the degree 
of swelling was evaluated through facial reference points’ variation. The presence of trismus was analyzed through 
measurement of the interincisal distance (IID). These assessments were obtained before the operation and 24h and 
48h after the surgery. 
Results:  Based on statistic analysis (pared t-student and Wilcoxon tests), the results showed a significant difference 
in the measurements of the degree of swelling and trismus of the treated sample. 8 mg of dexamethasone promoted 
a greater reduction of symptoms than 4mg of dexamethasone
Conclusions: The administration of 8 mg of the dexamethasone was more effective than 4mg of the dexamethasone 
to reduce the degree of swelling and trismus. However, it had no effect on pain control.
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Introduction
Third molars’ surgical extraction is a traumatic procedure 
and the most common in the Oral and Maxillofacial field.
(1-9) Being a highly vascularized area, predominantly 
constituted by loose connective tissue, a series of functio-
nal and structural alterations is expected, among them, 
the liberation of exudate and subsequent swelling, trismus 
and pain (9-11). To control postoperative inflammation 
and symptoms associated, it is necessary to provide an 
adequate anti-inflammatory therapy (1-15).
Hench et al. (1950) (6), reported the anti-inflammatory 
effects of cortisone and Adrenocorticotropic Hormone 
(ACTH) in the treatment of Rheumatoid Arthritis (RA), 
fact that increased its popularity among medical authorities. 
For several decades surgeons administered corticosteroids 
before or just after third molars’ surgery to reduce inflam-
mation and associated symptoms after oral surgery.
Corticosteroids’ mechanism of action includes the inhi-
bition of the enzyme Phospholipase A2 (PLA 2), which 
reduces the release of araquidonic acid in the cells of the 
inflamed focus. This will decrease prostaglandins’ and leu-
kotrienes’ synthesis, therefore reducing the accumulation 
of neutrophiles, what justifies, at least partly, the greatest 
power of corticosteroids compared to non steroidal anti-
inflammatory drugs (NSAID’S) (9-14).
Several studies have demonstrated a better effect in the 
control of the swelling and trismus when using steroid 
anti-inflammatory drugs versus non steroidal anti-
inflammatory drugs (6-22). However, the clinical use of 
this type of drugs should be moderate and rational, for 
limited time and dose because, according to endocrinology 
analyses, after the 5th day of use, the therapy has already 
begun to produce immunosuppresion, condition that in 
some patients may take up to 9 months to return to normal 
levels (10). Some studies show the use of different doses 
but they don’t compare them (7,9,12).
Taking into account these facts, the purpose of the pre-
sent study was to observe and compare the effects of two 
different dosages of  dexamethasone (4 mg and 8 mg), 
administered as one dose in the preoperative of the surgical 
third molar surgery. 
Materials and Methods
A prospective, randomized, controlled, blind, parallel-
group design study was performed with the approbation 
of  the Institutional Review Board Ethics in Research 
Commission of the University of Pernambuco; the surgi-
cal and experimental procedures were explained verbally 
and in writing, and informed consent was obtained before 
enrollment.
Thirty (30) patients with impacted lower third molars, 
between 18 and 26 years (mean 19.5 years) were operated 
by the same oral surgeon. A complete medical history was 
elicited and an oral examination was performed, including 
a panoramic radiograph, to confirm the need for third 
molar removal. The choice of which surgical procedures 
were going to be the experimental (8 mg of dexamethaso-
ne) and which were going to be part of the control sample 
(4 mg of dexamethasone) was made randomly. The oral 
surgeon was not allowed to know the dosages used for the 
respective sides. After 1 hour of the random choice of the 
side and the ingestion of a determined dose of dexame-
thasone, the surgical procedure was performed. 
For standardization of the sample, we used the following 
clinical criteria: 1) age between 14 and 30 years, 2) bilateral 
impacted third molars in the vertical, mesioangular or dis-
toangular positions (Winter’s classification), 3) equivalent 
degree of surgical difficulty comparing one side with the 
other, 4) no use of medication that could interfere with 
the healing process, and 5) no systemic disease.
All the patients made a mouthwash with clorexidine 0.2% 
before given local anesthesia (lidocaine 2% with epinefrine 
1:200.000) in the area to be operated. Local anesthesia 
of the inferior alveolar nerve and terminal infiltration of 
buccal fold was performed and the surgical procedure to 
remove third molars were made.
During the preoperative period, all patients had clinical 
and radiological evaluations, In the postoperative period, 
a nonsteroidal anti-inflammatory drug (Paracetamol 750 
mg; 1 tablet every 6 hours for 4 days) was prescribed.
The pain was evaluated in the postoperative period using 
a visual analog scale (VAS) of 10 mm. Mouth opening 
was measured using the maximum mouth opening before 
the surgical procedure and evaluated at 24 hours and 48 
hours post extraction. 
The evaluation of the facial swelling was performed using 
a horizontal and vertical guide with a flexible ruler and a 
Vernier caliper following control points as described by 
Neupert et al. (19). The facial measures corresponded to 
mentalis angle and four (4) facial points in relation with the 
angle of the mandible: 1. Ear tragus, 2. External canthal of 
the eye, 3. Nose wing and 4. Buccal comissure. The percen-
tage of facial swelling was obtained from the difference of 
the measures made in the preoperative and postoperative 
periods, dividing the result by the value obtained in the 
preoperative period and multiplying it by one-hundred 
(100). The evaluation of the postoperative facial swelling 
was carried out at 24 hours and 48 hours after the proce-
dure. The established period of time between the surgeries, 
determined previously, was fifteen (15) days.
The collected data were stored electronically and analyzed 
using the Statistical Analysis System (SAS) by means of 
descriptive statistic and the test t-student and test of Wil-
coxon of signaled ranks. The level of significance used in 
the statistical decisions was of 5,0%. 
Results
Thirty (30) patients of both genders, between 18 and 26 
years (mean 19.5 years) with impacted lower third molars 
comprised the sample of this study. 
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The time of surgery using 4mg of dexamethasone was 
27,59 ± 3,76 and using 8mg was 26,74 ± 5,54 without 
statistical differential among them (P=0,3250). It has no 
statistical differential between the used amount of anesthe-
tic with both amounts of dexamethasone (P = 0,8550).
The results of facial measures, comparing time and dosage 
are showed in Table 1. It can be observe the increase of all 
mean measures between preoperative and postoperative 
time, except the interincisal distance that diminished in 
the period of 48 hour postoperatively, demonstrating the 
reduction of buccal opening.  It was a statistical differen-
tial between the dosages in the preoperative measures of 
mandible angle to nose wing, and postoperative (24 and 
48 hours) in mentalis angle and interincisal distance.
The table 2 shows the Mean and Standard Deviation (SD) 
of the absolute difference between postoperative (with 24 
and 48 hours) and preoperative measures, in relation with 
the dosage. The only one Mean that does not increase was 
angle -  ear tragus.
The evolution of the pain during the week was regressi-
ve being that wasno statistical difference between both 
doses.
Discusion
Surgery of  impacted third molars is one of  the most 
frequent procedures in Oral and Maxillofacial Surgery 
(1-9) and can lead to immediate postoperative pain 
and discomfort (1-15). Trismus is a direct sequel of the 
postoperative swelling, being able of compressing nervous 
structures and generate mild to severe pain (5,9,11-15).
dexamethasone was chosen for the study because it has 
shown to be a drug of safe administration, if  time and 
dosages are strictly followed. The employed analgesic was 
Paracetamol, also a proven drug of safe administration 
and because of the fact that it doesn’t modify platelet’s ag-
gregation, coagulation time or neutrophile’s action (16).
The administration of dexamethasone 1 hour preopera-
tively, combined with the postoperative administration 
of 750 mg of paracetamol on the day of the operation 
and the 4 postoperative days, produced a clear reduction 
in postoperative pain and cheek swelling after impacted 
third molar removal. 
Comparing both doses, the use of 8 mg of dexamethasone 
has a statistical differential between the dosages in the 
preoperative measures of mandible angle to nose wing, 
and postoperative (24 and 48 hours) in mentalis angle 
and interincisal distance, demonstrating therefore the 
effectiveness of the medicine.
Neupert et al.19 reported that mouth opening as measured 
by the interincisal opening pre and postoperatively was 
improved with 4 mg of intravenous (IV) dexamethasone 
in the first few days after surgery, but no difference was 
noted between the corticosteroid and placebo groups for 
pain or swelling.
Twenty-four hours after surgery the restriction of mouth 
Table 1. Mean and Standard Deviation (SD) of the studied measures 
in relation with the evaluation time and dosage administered.   
Table 2. Mean and Standard Deviation (SD) between the postope-
rative (with 24 and 48 hours) and preoperative measures, in relation 
with the dosage.
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opening was reduced by 9,3% using 8 mg of dexametha-
sone, and 48 hours after surgery it increased to 11,74%, 
showing clinical and statistic differential.
Beirne and Hollander (11) reported that 125 mg of IV 
Methylprednisolone after third molar surgery reduced 
pain levels during the first postoperative day. Swelling 
was less with the glucocorticoid administration through 
postsurgery day three (3), but did not seem to be correla-
ted with pain levels. Trismus was minimally less with the 
corticosteroid medication, but not related to pain levels. 
No significant differences on pain control were found using 
neither 4 mg or 8 mg of dexamethasone. 
Dionne et al. (20) used 4 mg of dexamethasone given 12 
hours before and just after third molar surgery in thirty 
three (33) patients, twenty eight (28) received a placebo 
control. As markers of the extent of inflammation, sam-
ples of prostaglandin E2 (PGE2) and thromboxane B2 
(TxB2) were collected over time at the mandibular surgical 
sites. Dexamethasone significantly decreased the levels of 
PGE2 and TxB2, but had a minimal effect on reported 
pain on the day of surgery. Similar results were reported 
by Sisk and Bonnington (21) with Flurbiprofen 50 mg, 
with an effective reduction of pain levels in the first few 
hours after third molar surgery when compared with IV 
Methylprednisolone 125 mg.
The evolution of pain during the week was diminishing 
with the two dosages mainly the first 4 days, we could 
observe that the patines who werer treated with 8mg  had 
less pain but not showing statistical differential between 
the results.
In 2005 Tiwana et al. (23) reported that the administration 
of IV corticosteroids before third molar surgery offers a 
beneficial effect on health-related quality of life, we agreed 
with this, because having swelling and pain less the patient 
can return to his normal life.
Conclusion
We found that the dosage of  8 mg of  dexamethasone 
was statistically more efficient in the trismus and swelling 
control than the lower dosage, without any evidence in the 
reduction of pain levels after surgery.
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